Main Topics

Anti-PD-L1 immunotherapy combined with MEK inhibitor for metastatic colorectal cancer

At the 18th World Congress of Gastrointestinal Cancer, a phase I clinical study showed that anti-PD-L1 immunotherapy combined with MEK inhibitors can effectively treat microsatellite...

Application and evaluation of KRAS gene mutation method for colorectal cancer

Targeting drugs such as cetuximab and panitumumab have been widely used in clinic as effective therapeutic drugs for colorectal cancer. Clinical data show that patients with...

Lonsurf for the treatment of refractory metastatic colorectal cancer

Japanese pharmaceutical company Otsuka (Otsuka) recently received good news in the US regulatory aspects, FDA approved anti-cancer compound new drug Lo 3 ​​months in advancensurf...

Leukemia treatment options

Because leukemia classification and prognosis stratification are complex, there is no one-size-fits-all treatment method, and it is necessary to combine careful classification and prognosis stratification to...

Research progress in lymphoma

On June 17-20, 2015, the 13th International Lymphoma Conference was successfully held in Switzerland. 3700 representatives from 90 countries participated in the event. At the meeting,...

MD Anderson cancer center treatment story of a leukemia patient

Eddle and Pearlie Saddler, as his wife Pearlie hopes, “enjoy a regular life” in their South Carolina town. When they rested, Saddlers volunteered and participated in...

PD-1 inhibitor immunotherapy for B cell lymphoma

A review written by Young, MD, Anderson Cancer Center, USA explained the application of PD-1 inhibitor immunotherapy in B-cell lymphoma. (Blood. Online version on November 8,...

Study finds new ideas for leukemia treatment

A new study from McMaster University in Canada said that it has discovered a new treatment strategy for acute myeloid leukemia. By stimulating the production...

Peripheral T-cell lymphoma faces challenges

The Cleveland Clinic of the United States Eric D. His et al. Reported that the diagnosis of peripheral T cell lymphoma (PTCL) in the United...

AstraZeneca targeted drug Acalabrutinib has a new way to treat chronic lymphocytic leukemia

Acalabrutinib is a second-generation tyrosine kinase (BTK) inhibitor, a newer drug that can improve the survival of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma...

Pathogenesis and treatment of mature T cell tumors

Mature T-cell tumors, such as non-Hodgkin T-cell lymphoma, are highly invasive and drug-resistant, and patients often have a poor prognosis. Recently, “Nature” series of two...

Can obesity cause cancer?

Obesity not only runs counter to the aesthetics of people, but also causes many chronic diseases. Some studies have shown that body mass index (BMI)...

Need help? Our team is ready to assist you.

We wish a speedy recovery for your loved ones.

Scan the code